Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease

Clinical and Experimental Immunology

Volumn 163, Issue 3, 2011, Pages 346-353

  Giordani, L ^a   Quaranta, M G ^a   Marchesi, A ^c   Straface, E ^a   Pietraforte, D ^b   Villani, A ^c   Malorni, W ^a,d   Del Principe, D ^a,d   Viora, M ^a  

^a Departments of Therapeutic Research and Medicine Evaluation   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Istituto San Raffaele   (Italy)

Author keywords

B lymphocytes; Humoral immune response; Ig; Kawasaki disease; TLR 9

Indexed keywords

CD19 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODY-PRODUCING CELLS; ANTIGENS, CD19; B-LYMPHOCYTES; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INTERLEUKIN-17; INTERLEUKIN-6; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551705051     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04297.x     Document Type: Article

References (34)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-6.
2. Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol 1987; 1:218-29.
3. Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr 2007; 19:71-4.
4. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
5. Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease - cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol 2008; 6:394-401.
6. Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 2007; 20:298-303.
7. Yeung RSM. Pathogenesis and treatment of Kawasaki disease. Curr Opin Rheumatol 2005; 17:617-23.
8. Ikeda K, Yamaguchi K, Tanaka T etal. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol 2010; 160:246-55.
9. Matsubara T, Ichiyama T, Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 2005; 141:381-7.
10. Brogan PA, Shah V, Clarke LA, Dillon MJ, Klein N. T cell activation profiles in Kawasaki syndrome. Clin Exp Immunol 2008; 151:267-74.
11. Lee HH, Park IH, Shin JS, Kim DS. Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei Med J 2009; 50:493-504.
12. Grunebaum E, Blank M, Cohen S etal. The role of anti-endothelial cell antibodies in Kawasaki disease -in vitro and in vivo studies. Clin Exp Immunol 2002; 130:233-40.
13. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121:924-6.
14. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007; 220:251-69.
15. Wang GB, Li CR, Zu Y. Change of MyD88-independent signal transduction of Toll-like receptor 4 in immunological pathogenesis of Kawasaki disease. Zhonghua Er Ke Za Zhi 2007; 45:818-23.
16. Newburger JW, Takahashi M, Gerber MA etal. Diagnosis, treatment, and long-term management in Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young. American Heart Association. Pediatrics 2004; 114:1708-33.
17. Kobayashi T, Inoue Y, Takeuchi K etal. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113:2606-12.
18. Sedgwick JD, Holt PG. ELISA-plaque assay for the detection of single antibody-secreting cells. In: Kemeny DM, Challacombe SJ, eds. ELISA and other solid phase immunoassays. Chichester: Wiley, 1988:241-63.
19. Versteegen JM, Logtenberg T, Ballieux RE. Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level. J Immunol Methods 1988; 111:25-9.
20. Ehara H, Kiyohara K, Izumisawa Y, Ito T. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease. Cell Immunol 2010; 265:57-64.
21. Furukawa S, Matsubara T, Tsuji K etal. Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets. Infect Dis 1991; 163:416-17.
22. Shingadia D, O'Gorman M, Rowley AH, Shulman ST. Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Pediatr Res 2001; 50:538-43.
23. Jason J, Gregg L, Han A etal. Imunoregulatory changes in Kawasaki disease. Clin Immunol Immunopathol 1997; 84:296-306.
24. Furukawa S, Matsubara T, Yabuta K. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child 1992; 67:706-8.
25. Leung DY, Chu E, Wood N, Grady S, Meade R, Geha R. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983; 130:2002-4.
26. Leung DY, Siegel R, Grady S etal. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol 1982; 23:100-12.
27. Hornung V, Rothenfusser S, Britsch S etal. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-7.
28. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 2008; 9:1407-14.
29. Wang GB, Li CR, Zu Y, Yang WG. Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease. Zhonghua Er Ke Za Zhi 2008; 46:49-54.
30. Takeshita S, Kawase H, Shimizu T, Yoshida M, Sekine I. Increased production of serum IgA-class antibody to lipid A in Kawasaki disease. Pediatr Int 2002; 44:5-11.
31. Rowley AH, Eckerley CA, Jäck HM, Schulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997; 159:5946-55.
32. Rowley AH, Shulman ST, Mask CA etal. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182:1183-91.
33. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166:1334-43.
34. Sohn MH, Noh SY, Chang W, Shin KM, Kim DS. Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol 2003; 32:364-6.